The meeting of the Board of Directors of the company was held today i.e. Wednesday, May 20, 2026 at the Registered office of the company. The board has considered and approved the Audited ....
TAKE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts more than Nifty Microcap 250 and 5.0 pts more than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Take Solutions reported strong financial results for FY26 ending March 2026. Consolidated total income surged 495.68% YoY to ₹6,087 Lakhs, with consolidated net profit of ₹1,085 Lakhs and EPS of ₹0.74. Q4 FY26 showed exceptional performance with 3,400% YoY revenue growth. Standalone results also turned around with net profit of ₹272 Lakhs vs a loss of ₹6,974 Lakhs in FY25. However, auditors issued a Qualified Opinion on both standalone and consolidated results due to uncertainty over tax assets of ₹876 Lakhs (standalone) and ₹1,248 Lakhs (consolidated) related to disputed tax refunds pending before various forums. This is a repetitive qualification since FY23. The company noted significant turnaround following divestment of Ecron Acunova in FY25.
Strong operational turnaround with massive revenue and profit growth is positive. However, the auditors' qualified opinion on uncertain tax assets adds risk and may concern investors seeking clean audit reports. The repetitive nature of the qualification since FY23 suggests ongoing unresolved issues.